The Pharma Letter Podcast by Belong.life

Belong » Press » The Pharma Letter Podcast by Belong.life

July 2021.

Israel-based Belong.Life is the creator of the world’s largest social network for cancer patients, and has ambitions to provide a range of networks across therapy areas.

The platform may be of interest for drug developers and other industry participants looking for opportunities to conduct market research or marketing efforts, or to boost clinical trial enrolment.

In this episode, The Pharma Letter discusses the potential for the platform with its chief executive, Eliran Malki, and medical director, Daniel Vorobiof.

Listen Now >

Medika’s Top 20 ’24 Influential Voices to Follow

Dave is the world’s first LLM conversational AI oncology mentor for cancer patients, bringing a…

Trialbee & Belong.Life Partner to Increase Clinical Trial Awareness and Enrollment

Trialbee, the global leader in technology-driven patient recruitment for clinical trials, is launching an Omnichannel…

More on Using AI to Enhance Cancer Care

Dave AI provides the cognitive assistant with organized and valuable information to be delivered in…

Belong.Life is leading the charge in elevating patient engagement using conversational AI, big data and active patient communities. Belong’s key solutions include the world’s largest social and professional networks for people living with cancer (Belong – Beating Cancer Together) and multiple sclerosis (BelongMS), and the BelongAI health-grade patient engagement and support platforms (including Dave – Cancer Mentor, Tara for clinical trial matching and more) which utilize AI to proactively support and empower patients throughout their healthcare journey. By enhancing patient education and providing 24/7 support, as well as access to relevant clinical trials, Belong is contributing to improved healthcare outcomes globally.

BelongAI
Dave - Cancer Mentor

Belong Cancer

BelongMS

BelongIBD

BelongPSO

iBelong